| Literature DB >> 91458 |
D Papaioannou, P Geggie, J Klassen.
Abstract
Serum beta-2 microglobulin levels were measured in normal individuals and in breast cancer patients. It was observed that there was a significant rise in levels especially in advanced stages of the disease. It was concluded that patients with a beta-2 microglobulin/creatinine ratio of greater than 3.8 were likely to have metastatic breast cancer.Entities:
Mesh：
Substances：
Year: 1979 PMID： 91458 DOI： 10.1016/0009-8981(79)90137-2
Source DB: PubMed Journal: Clin Chim Acta ISSN： 0009-8981 Impact factor: 3.786